𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neoadjuvant therapy for oesophagogastric cancer

✍ Scribed by F. Lordick; H. J. Stein; C. Peschel; J. R. Siewert

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
155 KB
Volume
91
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Neoadjuvant therapy for pancreatic cance
Neoadjuvant therapy for pancreatic cancer
✍ J. Kleeff; H. Friess; M. W. BΓΌchler πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 54 KB πŸ‘ 1 views
Neoadjuvant chemotherapy for operable br
Neoadjuvant chemotherapy for operable breast cancer
✍ J. S. D. Mieog; J. A. van der Hage; C. J. H. van de Velde πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 155 KB πŸ‘ 1 views
Residual specimen cellularity after neoa
Residual specimen cellularity after neoadjuvant chemotherapy for breast cancer
✍ F. Peintinger; H. M. Kuerer; S. E. McGuire; R. Bassett; L. Pusztai; W. F. Symman πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 289 KB πŸ‘ 1 views

## Abstract ## Background Neoadjuvant chemotherapy for breast cancer reduces tumour cellularity, the percentage of the primary tumour area that is composed of invasive tumour cells. Minimal residual tumour cellularity (5 per cent or less of tumour area composed of invasive tumour cells) may be ass

Gene therapy for pancreatic cancer
Gene therapy for pancreatic cancer
✍ Shin Takeda; Akimasa Nakao; Koji Miyoshi; Hiroshi Takagi πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 36 KB πŸ‘ 2 views

It has been approximately 7 years since the introduction of gene therapy. Since conventional procedures such as surgery, chemotherapy, and radiotherapy have had limited therapeutic value for cancer patients, the evolution of gene therapy seems a promising alternative to many researchers and clinicia